Aurinia Pharmaceuticals Intrinsic Value – Aurinia Pharmaceuticals to Present at Prestigious Jefferies London Healthcare Conference
🌥️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a leading biopharmaceutical company that focuses on developing and commercializing innovative therapies to [...]
Aurinia Pharmaceuticals Stock Fair Value Calculation – Aurinia Pharmaceuticals Sees Negative Momentum, Closes at 6.84 in Market Recap
🌧️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc, a biopharmaceutical company, ended on a low note in the stock market with negative [...]
Chief Commercial Officer’s $96,902 Sale of Aurinia Pharmaceuticals Shares Signals Growing Investment Appeal
☀️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment [...]
Aurinia Pharmaceuticals hits record low at $4.96 on TSE: AUP shares
🌥️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a biopharmaceutical company that focuses on developing and commercializing therapies for autoimmune diseases. [...]
Aurinia Pharmaceuticals Intrinsic Stock Value – Aurinia Pharmaceuticals Posts Record Q4 Revenue Growth, On Track for Cash Flow Positivity
☀️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) (AUPH) is a biopharmaceutical company focused on the research and development of innovative therapeutics for [...]
Aurinia Pharmaceuticals Post Q3 Earnings: Assessing the Results
🌥️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) is a publicly traded biopharmaceutical company based in Victoria, British Columbia, Canada. The company specializes [...]
Swiss National Bank Increases Investment in Aurinia Pharmaceuticals
🌥️Trending News The Swiss National Bank has recently increased its stock portfolio with Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc., a publicly traded [...]
Aurinia Pharmaceuticals Intrinsic Stock Value – Aurinia Pharmaceuticals Inc: a Potential Winner in the Healthcare Sector?
☀️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a publicly-traded biopharmaceutical company based in Canada that specializes in the development of [...]
Aurinia Pharmaceuticals Intrinsic Value Calculation – AURINIA PHARMACEUTICALS Reports Second Quarter Earnings for Fiscal Year 2023
🌥️Earnings Overview AURINIA PHARMACEUTICALS ($NASDAQ:AUPH) released their Fiscal Year 2023 second quarter earnings report on June 30 2023. The company [...]
Aurinia Pharmaceuticals Intrinsic Value Calculation – AURINIA PHARMACEUTICALS Reports Q2 FY 2023 Earnings Results
🌥️Earnings Overview AURINIA PHARMACEUTICALS ($NASDAQ:AUPH) reported revenue of USD 41.5 million for the second quarter of Fiscal Year 2023, ending [...]
